Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Castle Creek Biosciences
company
About
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
- 11 - 50
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $20M
- Industries
- Biopharma,Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need.
It was founded in 2015 and headquartered in Pennsylvania, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
Castle Creek Biosciences has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Mar 25, 2020 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 25, 2020 | Debt Financing | $20M | 1 |
Horizon Technology Finance
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Castle Creek Biosciences is funded by 1 investors.
Horizon Technology Finance
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Horizon Technology Finance
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
